Newsletter
In this section, you will find the lastest news about our products
Scalable Bioreactor Solutions For Shear-Sensitive Cell Cultures
This patented rotating bioreactor technology is designed to break through the major barriers of cell culture, particularly shear stress, which has long compromised the viability and function of sensitive cells. This approach delivers both scalable manufacturing capabilities and high- performance tools for research environments. From stem cells, organoids, NK, T cells to microalgae and rare cell lines, Cellura’s innovation is powering the next generation of bioproduction across medicine, biotechnology, and sustainable food.
 |
Nanomaterials Crafted for Precision
This collection of nanomaterials is optimized for different applications, combining structural diversity with proven utility in healthcare and research.
|
Tools for Cell Viability and Apoptosis Detection
A wide selection of assay kits for cell viability and cell death is available for precise, multiparametric analysis of cell health, apoptosis, and cytotoxicity across diverse research applications.
|
Disinfectant Products for Safe and Sterile Laboratory Work
Discover how ConTaFree disinfectants provide effective, long-lasting antimicrobial protection, ensuring the integrity of your cell cultures, equipment, and reagents while supporting safe and sterile laboratory work.
|
Osteology Resources and Tools For Bone and Joint Research
Discover our complete range of products dedicated to the study of the skeleton and bone tissues, designed to support your research with precision and reliability.
|
Human Skin Materials for Dermatology Research
Discover our complete range of products dedicated to skin biology, combining DNA, RNA, primary cells, tissue sections, and human skin blocks.
|
Human Samples for Your Cardiovascular Research: Cells, Tissues, and Sections
Discover a wide range of products and solutions designed to support your research projects, from cellular modeling to histological analyses, to accelerate your discoveries in cardiology.
|
Clinical trials, Oncotarget: keep up to date with our latest news!
The Oncomedics Group Letter
|
Oncomedics Group Newsletter
Oncomedics Group announces its plans for 2024, including the launch of the Oncotarget kit for the study of solid tumors, as well as advances in clinical studies of metastatic colorectal cancer. They also strengthen their market presence by partnering with Genexpath for sarcoma and lymphoma diagnostics, affirming their commitment to innovation and medical advancement.
|
Partnership between Eurofins Biomnis and Oncomedics
Oncomedics - Oncomedics Group - is pleased to announce its partnership with Eurofins Biomnis, European leader in specialized medical biology.
|